[go: up one dir, main page]

AR052744A1 - Composiciones que comprenden componentes probioticos y edulcorantes - Google Patents

Composiciones que comprenden componentes probioticos y edulcorantes

Info

Publication number
AR052744A1
AR052744A1 ARP060101416A ARP060101416A AR052744A1 AR 052744 A1 AR052744 A1 AR 052744A1 AR P060101416 A ARP060101416 A AR P060101416A AR P060101416 A ARP060101416 A AR P060101416A AR 052744 A1 AR052744 A1 AR 052744A1
Authority
AR
Argentina
Prior art keywords
composition
edulcorant
compositions
components
probiotic
Prior art date
Application number
ARP060101416A
Other languages
English (en)
Inventor
Marko Stojanovic
Original Assignee
Iams Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iams Company filed Critical Iams Company
Publication of AR052744A1 publication Critical patent/AR052744A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Feed For Specific Animals (AREA)

Abstract

Una composicion que comprende (a) un componente probiotico; y (b) un componente edulcorante; en donde la composicion prácticamente carece de una base de goma de mascar. Dicha composicion en donde el componente probiotico comprende bacterias del grupo formado por Bacillus, Bacteroides, Bifidobacterium, Enterococcus, Lactobacillus, y Leuconostoc, y combinaciones de éstos, y en donde el edulcorante se selecciona del grupo gormado por monosacáridos, disacáridos, y mezclas de éstos. Dicha composicion que comprende de 0,001% a 10% de la bacteria y 50% a 99% de sorbitol, en peso de la composicion. Uso de dicha composicion para mejorar la salud de un mamífero.
ARP060101416A 2005-04-11 2006-04-10 Composiciones que comprenden componentes probioticos y edulcorantes AR052744A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67012505P 2005-04-11 2005-04-11
US11/384,050 US20100233312A9 (en) 2005-04-11 2006-03-17 Compositions comprising probiotic and sweetener components

Publications (1)

Publication Number Publication Date
AR052744A1 true AR052744A1 (es) 2007-03-28

Family

ID=36992608

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060101416A AR052744A1 (es) 2005-04-11 2006-04-10 Composiciones que comprenden componentes probioticos y edulcorantes

Country Status (8)

Country Link
US (1) US20100233312A9 (es)
EP (1) EP1868624A2 (es)
JP (1) JP2008535520A (es)
AR (1) AR052744A1 (es)
AU (1) AU2006235038B2 (es)
BR (1) BRPI0609456A2 (es)
CA (2) CA2604835C (es)
WO (1) WO2006110406A2 (es)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192733B2 (en) * 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
CA2609617C (en) 2005-05-31 2014-07-08 The Iams Company Feline probiotic lactobacilli
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
WO2007126990A2 (en) * 2006-03-29 2007-11-08 Nestec S.A. Dietary supplements containing probiotics
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
RU2436581C2 (ru) 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
FR2915388B1 (fr) * 2007-04-27 2010-12-24 Oreal Film hydrosoluble cosmetique
ATE498325T1 (de) * 2007-07-06 2011-03-15 Nutricia Nv Verwendung von probiotika und ballaststoffen bei diarrhö
CA2740434C (en) * 2007-10-26 2017-11-07 Brenda E. Moore Probiotic compositions and methods for inducing and supporting weight loss
US8071150B2 (en) * 2007-12-21 2011-12-06 Frito-Lay North America, Inc. Processing technique to thaw partially frozen fruits and vegetables and incorporating solids
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
IT1393415B1 (it) * 2009-01-27 2012-04-20 Probiotical Spa Integratore probiotico al gusto di cioccolato
SI2381799T1 (sl) * 2009-01-27 2018-12-31 Probiotical S.P.A. Probiotični dodatek z okusom čokolade
US20110027420A1 (en) * 2009-07-31 2011-02-03 Haile Mehansho Moisture migration reduction layer for a food product
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US9173423B2 (en) * 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US20110027417A1 (en) 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
US9210945B2 (en) * 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
US20110081320A1 (en) * 2009-10-06 2011-04-07 Nubiome, Inc. Treatment/Cure of Autoimmune Disease
US20110123677A1 (en) * 2009-11-25 2011-05-26 Pepsico, Inc. High acid beverage products and methods to extend probiotic stability
EP2624863B1 (en) 2010-10-07 2016-04-20 California Institute of Technology Probiotic therapies for autism
FR2968004B1 (fr) * 2010-11-29 2013-06-28 Sojasun Technologies Films naturels biodegradables a base de co-produits issus de processus industriels de traitement de graines.
US9254277B2 (en) 2010-12-23 2016-02-09 Hills's Pet Nutrition, Inc. Pet food compositions and methods for treating arthritis and inflammation associated with arthritis
WO2012087511A1 (en) 2010-12-23 2012-06-28 Hill's Pet Nutrition, Inc. Pet food compositions and methods for weight loss and maintenance
JP2014501536A (ja) 2011-01-14 2014-01-23 ザ・アイムス・カンパニー カロチノイドに関連する組成物及び方法
CA2841748C (en) 2011-07-15 2021-06-15 Nusirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
AU2012339863B2 (en) * 2011-11-14 2015-11-05 Mars, Incorporated Palatable pet foods and methods for improving the palatability of pet foods
JP2014533501A (ja) 2011-12-19 2014-12-15 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 糞品質を改良するための高消化性ペットフード
US9585925B1 (en) * 2012-05-04 2017-03-07 Vetnique Labs LLC Pet food supplement
WO2014036182A2 (en) 2012-08-29 2014-03-06 California Institute Of Technology Diagnosis and treatment of autism spectrum disorder
EP2919772B1 (en) 2012-11-13 2019-03-27 NuSirt Sciences, Inc. Pde5 inhibitors and leucine or a leucine metabolite for use in the treatment of diabetes
AU2014238377A1 (en) * 2013-03-15 2015-09-10 Nusirt Sciences, Inc. Treatment of pets with sirtuin activators
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
AU2015339290B8 (en) 2014-10-30 2021-08-26 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
WO2016069795A2 (en) 2014-10-30 2016-05-06 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
KR20170091157A (ko) 2014-12-23 2017-08-08 4디 파마 리서치 리미티드 피린 폴리펩티드 및 면역 조정
HUE035569T2 (en) 2014-12-23 2018-05-28 4D Pharma Res Ltd Bacteroides thetaiotaomicron strain and its use in reducing inflammation
BR112017017190B1 (pt) 2015-02-16 2022-08-30 Mars, Incorporated Método para produzir um alimento para animais de estimação
CN107529789A (zh) 2015-04-28 2018-01-02 马斯公司 制备灭菌湿宠物食品的方法
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
ES2753779T3 (es) 2015-06-15 2020-04-14 4D Pharma Res Ltd Blautia stercosis y wexlerae para la utilización en el tratamiento de enfermedades inflamatorias y autoinmunes
LT3360559T (lt) 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
HUE045413T2 (hu) 2015-06-15 2019-12-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
CN108513545B (zh) 2015-11-20 2020-11-03 4D制药研究有限公司 包含细菌菌株的组合物
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
RU2706953C1 (ru) * 2015-12-30 2019-11-21 Хиллс Пет Нутришн, Инк. Композиции корма для домашних животных с контролируемым высвобождением для доставки источника полифенола
SG11201807195VA (en) 2016-03-04 2018-09-27 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
US11707493B2 (en) 2016-05-23 2023-07-25 California Institute Of Technology Regulate gut microbiota to treat neurodegenerative disorders
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
USD806351S1 (en) 2016-09-06 2018-01-02 Mars, Incorporated Food product
USD805728S1 (en) 2016-09-06 2017-12-26 Mars, Incorporated Food product
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
GB201701417D0 (en) 2017-01-27 2017-03-15 Mars Inc Pet food
WO2018213204A1 (en) 2017-05-15 2018-11-22 Axial Biotherapeutics, Inc. Inhibitors of microbially induced amyloid
HUE054164T2 (hu) 2017-05-22 2021-08-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
ES2855701T3 (es) 2017-06-14 2021-09-24 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
JP2020523326A (ja) 2017-06-14 2020-08-06 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
WO2022036181A1 (en) 2020-08-14 2022-02-17 Church & Dwight Co., Inc. Microbial compositions to increase the production of pca from polyphenols
US20230256002A1 (en) * 2022-02-11 2023-08-17 Keith Allen Garleb Hard lozenge made with dietary fiber

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055676A (en) * 1975-05-20 1977-10-25 The Quaker Oats Company Replacement of sugar in a sugar-containing food and process
US4565702A (en) * 1984-06-04 1986-01-21 Warner-Lambert Company Dietary fiber food products and method of manufacture
DE69019975T2 (de) * 1990-11-26 1995-10-05 Nestle Sa Verfahren und Vorrichtung zum Herstellen von Nahrungsmitteln durch Koch-Koextrusion.
JPH08126473A (ja) * 1994-09-08 1996-05-21 Fuji Oil Co Ltd 油性組成物およびその製法並びにそれを用いた油性被覆菓子
DE29724816U1 (de) * 1997-01-09 2004-07-22 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
US6133323A (en) * 1997-04-09 2000-10-17 The Iams Company Process for enhancing immune response in animals using β-carotene as a dietary supplement
ATE214597T1 (de) * 1997-12-19 2002-04-15 Merck Patent Gmbh Mehrschichttablette enthaltend probiotische mikroorganismen wie z.b. lactobacilli oder bifidobakterien
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
EP1074250B1 (en) * 1998-04-30 2004-03-24 Morinaga Milk Industry Co., Ltd. Sugar coated tablets
US20040161422A1 (en) * 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
CA2368635C (en) * 1999-05-12 2009-11-10 Hercules Incorporated Food composition with high solids content, a method for its preparation as well as the use of carrageenans for gelling a food composition
ES2248087T5 (es) * 1999-05-27 2012-02-21 The Iams Company Procedimiento para fabricar un producto para aumentar la respuesta inmune de animales de compañía usando una combinación de antioxidantes.
DE19937361A1 (de) * 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
JP2001321094A (ja) * 2000-05-12 2001-11-20 Kenji Tokunaga 乳酸菌を含むローヤルゼリー錠剤の製造方法
ES2262667T3 (es) * 2000-05-25 2006-12-01 Societe Des Produits Nestle S.A. Probioticos nuevos para aplicaciones en alimento para animales de compañia.
GB0027761D0 (en) * 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
GB2382528B (en) * 2001-11-12 2004-05-05 Mars Inc A consumable composition for the development of a healthy gastrointestinal tract
US20050008735A1 (en) * 2002-02-11 2005-01-13 Pearce Tony M. Chocolate polymer snacks
EP1344458A1 (en) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
ITBO20020564A1 (it) * 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
ITMI20022343A1 (it) * 2002-11-05 2004-05-06 Biofarm Srl Pellicola a rapida dissoluzione in acqua, contenente sistanze cosmetiche, aromatiche, farmaceutiche o alimentari.
US20040202698A1 (en) * 2003-04-02 2004-10-14 The Procter & Gamble Company Drug delivery systems comprising an encapsulated active ingredient
US20050136095A1 (en) * 2003-12-22 2005-06-23 Brian Levy Drug delivery device with suture ring
CA2570126C (en) * 2004-07-01 2014-08-12 General Mills, Inc. Cultures encapsulated with chocolate food products coated with chocolate and methods of preparation
US20060228448A1 (en) * 2005-04-11 2006-10-12 The Iams Company Pet food compositions comprising two components

Also Published As

Publication number Publication date
WO2006110406A3 (en) 2007-07-12
BRPI0609456A2 (pt) 2010-04-06
EP1868624A2 (en) 2007-12-26
CA2875889C (en) 2018-04-24
US20070218164A1 (en) 2007-09-20
CA2604835C (en) 2014-12-30
AU2006235038A1 (en) 2006-10-19
AU2006235038B2 (en) 2011-05-19
US20100233312A9 (en) 2010-09-16
CA2875889A1 (en) 2006-10-19
WO2006110406A2 (en) 2006-10-19
JP2008535520A (ja) 2008-09-04
CA2604835A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
AR052744A1 (es) Composiciones que comprenden componentes probioticos y edulcorantes
AR066878A1 (es) Composiciones cosmeticas con resistencia a la transferencia mejorada
CL2013001367A1 (es) Conjunto de composiciones nutricionales para lactantes y niños pequeños que comprende una primera composicion para lactantes de 0 a 6 meses, una segunda composicion para lactantes de 6 meses y 1 año, y una tercera composicion para niños pequeños de 1 a 2 años, donde la primera y segunda composicion comprenden probioticos difiriendo entre si por la cantidad y/o naturaleza de los mismos; y su uso para prevenir y/o tratar diarrea entre otros desordenes.
CR20150097A (es) Composición inmunogénica
BRPI0922924A2 (pt) composições para melhoria da saúde oral, método de uso de uma composição e uso de pelo menos uma bactéria benéfica para a preparação de uma composição para melhoria da saúde oral
ATE474585T1 (de) Probiotische enterokokken für eine verbesserte immunität
HN2005000795A (es) Pirimidinas como antagonistas del receptor de prostaglandina d2
BRPI0921002A8 (pt) Composições para tratamento bucal compreendendo sílica fundida e seu uso
AR058648A1 (es) Sistema abrasivo para composiciones de cuidado oral
CL2012001950A1 (es) Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño
CL2011001940A1 (es) Uso de lactobacillus rhamnosus cncm i-4007 y una formulacion de prebioticos que comprende oligofructosa e inulina para apoyar la perdida de peso y/o mantenimiento del peso en humanos y/o animales.
CL2008003016A1 (es) Composicion para tratamiento de lavanderia que comprende una base de tratamiento de lavanderia y desde 0,01 a 10% en peso de particulas de film laminar concavas coloreadas.
ATE528012T1 (de) Uronsäure und probiotika
CL2008001157A1 (es) Compuestos derivados de quinolina-carboxamida, antagonistas de p2y12; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; composicion de una combinacion de dichos compuestos; y uso del compuesto en el tratamiento de trastornos cardiovasculares, tromboembolismo, infarto agudo al miocardio.
CO6290630A2 (es) Composición oral que contiene amino ácidos y particulas pequeñas
CL2009001560A1 (es) Composición nutricional para bebes que comprende una mezcla de oligosacáridos compuesta de oligosacáridos n-acetilados, galactooligosácaridos y oligosacáridos sialilados; y su uso.
ECSP11010975A (es) Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales
CL2008001855A1 (es) Compuestos ciclicos condensados derivados del boro; composicion farmaceutica; y uso en el tratamiento y/o prevencion de una enfermedad infecciosa.
SG10201901259RA (en) Prebiotic formulations and methods of use
TW200716584A (en) Dihydrobenzofuran derivatives and uses thereof
AR077199A1 (es) Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia
ATE537707T1 (de) Lactobacillus paracasei und gewichtskontrolle
IN2012DN01638A (es)
CR20110100A (es) Nuevos derivados de sulfamida sustituida
SG165315A1 (en) Alpha2c adrenoreceptor agonists

Legal Events

Date Code Title Description
FG Grant, registration